CN Stock MarketDetailed Quotes

300238 Guanhao Biotech

Watchlist
  • 10.07
  • +0.13+1.31%
Market Closed May 31 15:00 CST
2.67BMarket Cap114.43P/E (TTM)

Guanhao Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-24.03%96.73M
-16.74%105.14M
-4.52%131.69M
-14.40%136.3M
-28.08%127.32M
-20.73%126.28M
-13.96%137.91M
-8.33%159.23M
33.97%177.02M
1.99%159.31M
Notes receivable and accounts receivable
-24.88%74.83M
-15.05%61.14M
-12.51%77.73M
-23.21%81.51M
-13.36%99.6M
-32.55%71.98M
-19.20%88.85M
-15.12%106.15M
-6.74%114.97M
-8.29%106.71M
-Accounts receivable
-24.88%74.83M
-15.05%61.14M
-12.51%77.73M
-23.21%81.51M
-13.36%99.6M
-32.55%71.98M
-19.20%88.85M
-14.66%106.15M
-6.74%114.97M
-8.29%106.71M
Other receivables (including interest and dividends)
30.07%14.11M
52.90%13.36M
-55.33%7.51M
0.78%12.99M
-15.65%10.85M
-20.86%8.74M
17.06%16.82M
-25.79%12.89M
-0.27%12.86M
-23.11%11.04M
-Other receivable
----
----
----
0.78%12.99M
----
-20.86%8.74M
----
-25.79%12.89M
----
-23.11%11.04M
Advance payment
-35.79%10.09M
-70.96%7.22M
-13.73%22.77M
-40.24%10.22M
-15.04%15.71M
125.24%24.85M
124.51%26.4M
25.45%17.1M
52.56%18.49M
-26.13%11.03M
Inventories
1.98%68.97M
16.09%71.6M
2.90%67.87M
10.15%69.83M
-45.01%67.63M
-56.12%61.68M
-52.10%65.96M
-50.45%63.39M
-0.95%122.97M
10.76%140.55M
Other current assets
198.24%10.12M
64.32%8.82M
-74.38%1.82M
26.22%5.3M
-51.59%3.39M
-20.79%5.37M
-50.56%7.12M
-32.38%4.2M
-3.40%7.01M
-27.01%6.78M
Total current assets
-15.30%274.84M
-10.58%267.28M
-9.81%309.4M
-12.90%316.14M
-28.42%324.5M
-31.36%298.89M
-23.51%343.06M
-21.76%362.96M
10.07%453.32M
-0.60%435.41M
Non Current assets
Other equity investment
0.00%15.15M
0.00%15.15M
0.00%15.15M
0.00%15.15M
0.00%15.15M
0.00%15.15M
-50.41%15.15M
-50.41%15.15M
-27.69%15.15M
-27.69%15.15M
Investment real estate
--8.9M
--9.01M
----
----
----
----
----
----
----
----
Long-term equity investment
-2.98%16.8M
-2.76%16.93M
-70.04%17.02M
-70.17%17.15M
-70.36%17.31M
-70.53%17.41M
-6.88%56.81M
-6.03%57.49M
-12.14%58.4M
-11.31%59.06M
Fixed assets
----
----
----
-8.57%176.77M
----
-8.61%182.73M
----
-6.12%193.34M
----
-8.45%199.94M
Constru in process
----
----
----
367.50%11.28M
----
16.17%2.8M
----
8.08%2.41M
----
8.08%2.41M
Intangible assets
-10.26%76.27M
-10.09%78.66M
-10.94%80.48M
39.65%82.88M
37.60%84.99M
36.40%87.49M
35.42%90.36M
-14.43%59.35M
-14.16%61.77M
-13.31%64.14M
Development expenditure
35.36%21.6M
31.22%20.47M
25.00%18.83M
14.24%16.56M
52.83%15.96M
89.80%15.6M
114.87%15.07M
126.21%14.5M
80.90%10.44M
45.12%8.22M
Goodwill
----
----
----
----
----
----
----
----
0.00%214.33M
0.00%214.33M
Long deferred expense
-46.35%4.02M
-53.69%3.69M
-64.46%4.28M
-49.27%6.71M
-48.45%7.49M
-48.34%7.98M
-27.11%12.04M
-19.07%13.23M
-36.72%14.52M
-36.09%15.44M
Deferred tax assets
13.56%14.88M
13.76%14.97M
-65.32%13.8M
-64.35%13.87M
-68.04%13.1M
-68.25%13.16M
-24.00%39.78M
-28.28%38.92M
-22.51%40.99M
-24.37%41.44M
Usufruct assets
-44.26%15.08M
-44.64%16.09M
-26.41%22.2M
-29.81%26.24M
-33.02%27.05M
-32.70%29.06M
-11.59%30.16M
5.98%37.38M
49.58%40.39M
-12.99%43.18M
Other non current assets
--359.5K
--390.88K
1,204.60%1.76M
----
----
----
-75.98%135K
----
-99.71%45.1K
----
Total non current assets
13.10%417.53M
10.75%411.32M
-17.89%371.03M
-15.09%366.62M
-43.62%369.17M
-44.01%371.38M
-34.35%451.88M
-37.97%431.77M
-7.72%654.74M
-11.12%663.32M
Total assets
-0.19%692.37M
1.24%678.59M
-14.40%680.43M
-14.09%682.76M
-37.40%693.67M
-39.00%670.27M
-30.07%794.94M
-31.48%794.72M
-1.19%1.11B
-7.23%1.1B
Liabilities
Current liabilities
Short term loan
-51.05%23.52M
-50.01%24.52M
-49.01%25.52M
-28.73%36.03M
-5.91%48.05M
-4.88%49.05M
-3.77%50.04M
-30.11%50.56M
-29.66%51.06M
-49.88%51.56M
Notes payable and accounts payable
74.11%8M
1,254.76%29.32M
99.89%3.6M
29.54%2.61M
201.76%4.6M
15.09%2.16M
-25.71%1.8M
5.94%2.01M
-40.68%1.52M
-37.44%1.88M
-Accounts payable
74.11%8M
1,254.76%29.32M
99.89%3.6M
29.54%2.61M
201.76%4.6M
15.09%2.16M
-25.71%1.8M
5.94%2.01M
-40.68%1.52M
-37.44%1.88M
Contract liabilities
18.09%31.8M
-22.33%21.97M
33.17%27.99M
110.22%29.79M
98.37%26.93M
65.46%28.29M
84.42%21.02M
1.43%14.17M
-32.17%13.57M
-37.16%17.1M
Advance receipts
----
----
--16.66K
--20.96K
----
----
----
----
----
----
Salaries payable
1.44%8.75M
-0.66%17.84M
-24.86%16.24M
-23.33%13.01M
-28.55%8.62M
-26.32%17.96M
35.40%21.61M
10.76%16.97M
42.11%12.07M
2.78%24.37M
Taxs payable
-43.91%12.31M
-50.15%8.12M
-42.74%11.61M
-50.30%9.89M
-7.96%21.94M
-17.16%16.3M
-8.82%20.28M
17.83%19.9M
386.23%23.84M
312.72%19.67M
Other payable (including interest and dividends)
-18.45%56.33M
-3.37%63.56M
5.52%71.43M
-2.77%70.2M
-21.57%69.07M
-20.10%65.77M
-28.52%67.69M
-36.42%72.2M
-20.32%88.06M
-8.29%82.31M
-Other payable
----
----
----
-2.77%70.2M
----
-20.10%65.77M
----
-36.42%72.2M
----
-8.29%82.31M
Non current liabilities due within one year
-3.66%7.43M
-18.95%6.07M
-86.68%4.68M
-75.26%9.47M
-87.43%7.71M
-88.33%7.49M
-41.76%35.12M
-33.31%38.26M
81.59%61.32M
5.46%64.2M
Other current liabilities
-23.95%1.3M
-33.35%1.31M
-35.44%834.31K
112.51%2M
117.48%1.71M
67.36%1.97M
6.95%1.29M
-6.89%939.41K
-41.81%786.06K
-2.93%1.18M
Total current liabilities
-20.78%149.43M
-8.61%172.72M
-26.02%161.92M
-19.53%173.01M
-25.22%188.62M
-27.94%188.99M
-15.90%218.85M
-26.46%215.01M
-0.77%252.24M
-16.32%262.27M
Current liabilities
Long term loan
--36.05M
--12.02M
----
----
----
----
----
----
----
----
Deferred tax liabilities
-1.95%4.89M
-1.53%4.9M
-21.05%5.44M
-53.61%5.47M
-57.60%4.98M
-57.66%4.97M
-42.32%6.89M
-0.68%11.78M
1.27%11.75M
3.80%11.74M
Long term deferred income
-9.76%20.34M
-9.63%20.65M
-24.64%20.95M
-28.46%22.33M
-42.15%22.54M
-44.19%22.85M
-38.99%27.8M
-35.81%31.21M
-21.45%38.97M
-17.21%40.94M
Lease liabilities
-51.95%10.01M
-46.45%12.06M
-27.59%20.44M
-38.26%19.65M
-42.29%20.83M
-36.78%22.52M
11.61%28.23M
12.95%31.83M
93.52%36.1M
-8.50%35.62M
Total non current liabilities
47.40%71.28M
-1.43%49.62M
-25.57%46.83M
-36.59%47.45M
-44.30%48.36M
-42.99%50.34M
-44.12%62.92M
-36.84%74.83M
-35.43%86.82M
-42.77%88.3M
Total liabilities
-6.87%220.71M
-7.10%222.33M
-25.92%208.75M
-23.94%220.46M
-30.11%236.99M
-31.73%239.33M
-24.43%281.77M
-29.46%289.84M
-12.76%339.06M
-25.04%350.58M
Shareholders equity
Paid-in capital
0.00%265.16M
0.00%265.16M
0.00%265.16M
0.00%265.16M
0.00%265.16M
0.00%265.16M
0.00%265.16M
0.00%265.16M
0.00%265.16M
0.00%265.16M
Capital reserve funds
0.00%600.27M
0.00%600.27M
0.43%600.27M
0.43%600.27M
0.43%600.27M
0.43%600.27M
0.00%597.71M
0.00%597.71M
0.00%597.71M
-0.22%597.71M
Surplus reserve funds
7.43%47.11M
7.43%47.11M
-5.74%43.85M
-5.74%43.85M
0.00%43.85M
0.00%43.85M
27.08%46.52M
27.08%46.52M
19.79%43.85M
19.79%43.85M
Retained profit
5.71%-331.09M
7.43%-345.48M
-10.78%-331.99M
-9.75%-342.52M
-704.59%-351.14M
-470.49%-373.23M
-317.17%-299.67M
-241.48%-312.08M
61.84%-43.64M
50.67%-65.42M
Other composite income
4.97%-46.54M
8.37%-46.46M
13.10%-48.04M
7.48%-49.49M
15.41%-48.98M
11.63%-50.71M
-41.07%-55.28M
-37.26%-53.49M
-54.40%-57.9M
-51.41%-57.38M
Shareholders equity without minority interests
5.06%534.9M
7.26%520.59M
-4.54%529.25M
-4.88%517.27M
-36.76%509.16M
-38.09%485.34M
-29.68%554.44M
-29.29%543.82M
7.70%805.18M
7.35%783.92M
Minority interests
-20.54%-63.25M
-18.26%-64.33M
-39.49%-57.57M
-41.19%-54.97M
-45.05%-52.47M
-52.13%-54.4M
-68.47%-41.27M
-94.22%-38.93M
-142.68%-36.18M
-162.77%-35.76M
Total shareholder equity
3.28%471.65M
5.87%456.26M
-8.08%471.68M
-8.43%462.3M
-40.61%456.68M
-42.40%430.94M
-32.83%513.17M
-32.60%504.89M
4.95%769.01M
4.40%748.16M
Total liabilityies and equity
-0.19%692.37M
1.24%678.59M
-14.40%680.43M
-14.09%682.76M
-37.40%693.67M
-39.00%670.27M
-30.07%794.94M
-31.48%794.72M
-1.19%1.11B
-7.23%1.1B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -24.03%96.73M-16.74%105.14M-4.52%131.69M-14.40%136.3M-28.08%127.32M-20.73%126.28M-13.96%137.91M-8.33%159.23M33.97%177.02M1.99%159.31M
Notes receivable and accounts receivable -24.88%74.83M-15.05%61.14M-12.51%77.73M-23.21%81.51M-13.36%99.6M-32.55%71.98M-19.20%88.85M-15.12%106.15M-6.74%114.97M-8.29%106.71M
-Accounts receivable -24.88%74.83M-15.05%61.14M-12.51%77.73M-23.21%81.51M-13.36%99.6M-32.55%71.98M-19.20%88.85M-14.66%106.15M-6.74%114.97M-8.29%106.71M
Other receivables (including interest and dividends) 30.07%14.11M52.90%13.36M-55.33%7.51M0.78%12.99M-15.65%10.85M-20.86%8.74M17.06%16.82M-25.79%12.89M-0.27%12.86M-23.11%11.04M
-Other receivable ------------0.78%12.99M-----20.86%8.74M-----25.79%12.89M-----23.11%11.04M
Advance payment -35.79%10.09M-70.96%7.22M-13.73%22.77M-40.24%10.22M-15.04%15.71M125.24%24.85M124.51%26.4M25.45%17.1M52.56%18.49M-26.13%11.03M
Inventories 1.98%68.97M16.09%71.6M2.90%67.87M10.15%69.83M-45.01%67.63M-56.12%61.68M-52.10%65.96M-50.45%63.39M-0.95%122.97M10.76%140.55M
Other current assets 198.24%10.12M64.32%8.82M-74.38%1.82M26.22%5.3M-51.59%3.39M-20.79%5.37M-50.56%7.12M-32.38%4.2M-3.40%7.01M-27.01%6.78M
Total current assets -15.30%274.84M-10.58%267.28M-9.81%309.4M-12.90%316.14M-28.42%324.5M-31.36%298.89M-23.51%343.06M-21.76%362.96M10.07%453.32M-0.60%435.41M
Non Current assets
Other equity investment 0.00%15.15M0.00%15.15M0.00%15.15M0.00%15.15M0.00%15.15M0.00%15.15M-50.41%15.15M-50.41%15.15M-27.69%15.15M-27.69%15.15M
Investment real estate --8.9M--9.01M--------------------------------
Long-term equity investment -2.98%16.8M-2.76%16.93M-70.04%17.02M-70.17%17.15M-70.36%17.31M-70.53%17.41M-6.88%56.81M-6.03%57.49M-12.14%58.4M-11.31%59.06M
Fixed assets -------------8.57%176.77M-----8.61%182.73M-----6.12%193.34M-----8.45%199.94M
Constru in process ------------367.50%11.28M----16.17%2.8M----8.08%2.41M----8.08%2.41M
Intangible assets -10.26%76.27M-10.09%78.66M-10.94%80.48M39.65%82.88M37.60%84.99M36.40%87.49M35.42%90.36M-14.43%59.35M-14.16%61.77M-13.31%64.14M
Development expenditure 35.36%21.6M31.22%20.47M25.00%18.83M14.24%16.56M52.83%15.96M89.80%15.6M114.87%15.07M126.21%14.5M80.90%10.44M45.12%8.22M
Goodwill --------------------------------0.00%214.33M0.00%214.33M
Long deferred expense -46.35%4.02M-53.69%3.69M-64.46%4.28M-49.27%6.71M-48.45%7.49M-48.34%7.98M-27.11%12.04M-19.07%13.23M-36.72%14.52M-36.09%15.44M
Deferred tax assets 13.56%14.88M13.76%14.97M-65.32%13.8M-64.35%13.87M-68.04%13.1M-68.25%13.16M-24.00%39.78M-28.28%38.92M-22.51%40.99M-24.37%41.44M
Usufruct assets -44.26%15.08M-44.64%16.09M-26.41%22.2M-29.81%26.24M-33.02%27.05M-32.70%29.06M-11.59%30.16M5.98%37.38M49.58%40.39M-12.99%43.18M
Other non current assets --359.5K--390.88K1,204.60%1.76M-------------75.98%135K-----99.71%45.1K----
Total non current assets 13.10%417.53M10.75%411.32M-17.89%371.03M-15.09%366.62M-43.62%369.17M-44.01%371.38M-34.35%451.88M-37.97%431.77M-7.72%654.74M-11.12%663.32M
Total assets -0.19%692.37M1.24%678.59M-14.40%680.43M-14.09%682.76M-37.40%693.67M-39.00%670.27M-30.07%794.94M-31.48%794.72M-1.19%1.11B-7.23%1.1B
Liabilities
Current liabilities
Short term loan -51.05%23.52M-50.01%24.52M-49.01%25.52M-28.73%36.03M-5.91%48.05M-4.88%49.05M-3.77%50.04M-30.11%50.56M-29.66%51.06M-49.88%51.56M
Notes payable and accounts payable 74.11%8M1,254.76%29.32M99.89%3.6M29.54%2.61M201.76%4.6M15.09%2.16M-25.71%1.8M5.94%2.01M-40.68%1.52M-37.44%1.88M
-Accounts payable 74.11%8M1,254.76%29.32M99.89%3.6M29.54%2.61M201.76%4.6M15.09%2.16M-25.71%1.8M5.94%2.01M-40.68%1.52M-37.44%1.88M
Contract liabilities 18.09%31.8M-22.33%21.97M33.17%27.99M110.22%29.79M98.37%26.93M65.46%28.29M84.42%21.02M1.43%14.17M-32.17%13.57M-37.16%17.1M
Advance receipts ----------16.66K--20.96K------------------------
Salaries payable 1.44%8.75M-0.66%17.84M-24.86%16.24M-23.33%13.01M-28.55%8.62M-26.32%17.96M35.40%21.61M10.76%16.97M42.11%12.07M2.78%24.37M
Taxs payable -43.91%12.31M-50.15%8.12M-42.74%11.61M-50.30%9.89M-7.96%21.94M-17.16%16.3M-8.82%20.28M17.83%19.9M386.23%23.84M312.72%19.67M
Other payable (including interest and dividends) -18.45%56.33M-3.37%63.56M5.52%71.43M-2.77%70.2M-21.57%69.07M-20.10%65.77M-28.52%67.69M-36.42%72.2M-20.32%88.06M-8.29%82.31M
-Other payable -------------2.77%70.2M-----20.10%65.77M-----36.42%72.2M-----8.29%82.31M
Non current liabilities due within one year -3.66%7.43M-18.95%6.07M-86.68%4.68M-75.26%9.47M-87.43%7.71M-88.33%7.49M-41.76%35.12M-33.31%38.26M81.59%61.32M5.46%64.2M
Other current liabilities -23.95%1.3M-33.35%1.31M-35.44%834.31K112.51%2M117.48%1.71M67.36%1.97M6.95%1.29M-6.89%939.41K-41.81%786.06K-2.93%1.18M
Total current liabilities -20.78%149.43M-8.61%172.72M-26.02%161.92M-19.53%173.01M-25.22%188.62M-27.94%188.99M-15.90%218.85M-26.46%215.01M-0.77%252.24M-16.32%262.27M
Current liabilities
Long term loan --36.05M--12.02M--------------------------------
Deferred tax liabilities -1.95%4.89M-1.53%4.9M-21.05%5.44M-53.61%5.47M-57.60%4.98M-57.66%4.97M-42.32%6.89M-0.68%11.78M1.27%11.75M3.80%11.74M
Long term deferred income -9.76%20.34M-9.63%20.65M-24.64%20.95M-28.46%22.33M-42.15%22.54M-44.19%22.85M-38.99%27.8M-35.81%31.21M-21.45%38.97M-17.21%40.94M
Lease liabilities -51.95%10.01M-46.45%12.06M-27.59%20.44M-38.26%19.65M-42.29%20.83M-36.78%22.52M11.61%28.23M12.95%31.83M93.52%36.1M-8.50%35.62M
Total non current liabilities 47.40%71.28M-1.43%49.62M-25.57%46.83M-36.59%47.45M-44.30%48.36M-42.99%50.34M-44.12%62.92M-36.84%74.83M-35.43%86.82M-42.77%88.3M
Total liabilities -6.87%220.71M-7.10%222.33M-25.92%208.75M-23.94%220.46M-30.11%236.99M-31.73%239.33M-24.43%281.77M-29.46%289.84M-12.76%339.06M-25.04%350.58M
Shareholders equity
Paid-in capital 0.00%265.16M0.00%265.16M0.00%265.16M0.00%265.16M0.00%265.16M0.00%265.16M0.00%265.16M0.00%265.16M0.00%265.16M0.00%265.16M
Capital reserve funds 0.00%600.27M0.00%600.27M0.43%600.27M0.43%600.27M0.43%600.27M0.43%600.27M0.00%597.71M0.00%597.71M0.00%597.71M-0.22%597.71M
Surplus reserve funds 7.43%47.11M7.43%47.11M-5.74%43.85M-5.74%43.85M0.00%43.85M0.00%43.85M27.08%46.52M27.08%46.52M19.79%43.85M19.79%43.85M
Retained profit 5.71%-331.09M7.43%-345.48M-10.78%-331.99M-9.75%-342.52M-704.59%-351.14M-470.49%-373.23M-317.17%-299.67M-241.48%-312.08M61.84%-43.64M50.67%-65.42M
Other composite income 4.97%-46.54M8.37%-46.46M13.10%-48.04M7.48%-49.49M15.41%-48.98M11.63%-50.71M-41.07%-55.28M-37.26%-53.49M-54.40%-57.9M-51.41%-57.38M
Shareholders equity without minority interests 5.06%534.9M7.26%520.59M-4.54%529.25M-4.88%517.27M-36.76%509.16M-38.09%485.34M-29.68%554.44M-29.29%543.82M7.70%805.18M7.35%783.92M
Minority interests -20.54%-63.25M-18.26%-64.33M-39.49%-57.57M-41.19%-54.97M-45.05%-52.47M-52.13%-54.4M-68.47%-41.27M-94.22%-38.93M-142.68%-36.18M-162.77%-35.76M
Total shareholder equity 3.28%471.65M5.87%456.26M-8.08%471.68M-8.43%462.3M-40.61%456.68M-42.40%430.94M-32.83%513.17M-32.60%504.89M4.95%769.01M4.40%748.16M
Total liabilityies and equity -0.19%692.37M1.24%678.59M-14.40%680.43M-14.09%682.76M-37.40%693.67M-39.00%670.27M-30.07%794.94M-31.48%794.72M-1.19%1.11B-7.23%1.1B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg